- Report
- June 2026
- 200 Pages
Italy
From €2762EUR$2,990USD£2,310GBP
- Report
- May 2025
- 190 Pages
Global
From €5496EUR$5,950USD£4,597GBP
- Report
- September 2024
- 150 Pages
Asia Pacific
From €3574EUR$3,869USD£2,989GBP
- Report
- September 2025
- 199 Pages
Global
From €4614EUR$4,995USD£3,859GBP
From €3187EUR$3,450USD£2,665GBP
- Report
- July 2025
- 190 Pages
Global
From €4110EUR$4,450USD£3,438GBP
- Report
- June 2025
- 89 Pages
Nigeria
From €2263EUR$2,450USD£1,893GBP
- Report
- October 2025
- 98 Pages
Oman
From €4156EUR$4,500USD£3,477GBP
- Report
- February 2024
- 138 Pages
Global
From €3500EUR$4,059USD£3,030GBP
The In Vitro Diagnostics (IVD) Infectious Disease market is a segment of the larger IVD industry that focuses on the diagnosis and monitoring of infectious diseases. It includes a range of products and services, such as tests for the detection of bacteria, viruses, fungi, and parasites, as well as tests for the identification of drug-resistant organisms. These tests are used to diagnose and monitor the progression of infectious diseases, as well as to guide treatment decisions.
The IVD Infectious Disease market is driven by the increasing prevalence of infectious diseases, the emergence of new and drug-resistant pathogens, and the need for rapid and accurate diagnosis. Additionally, technological advances in molecular diagnostics, such as PCR and next-generation sequencing, have enabled the development of more sensitive and specific tests.
Notable companies in the IVD Infectious Disease market include Abbott, Becton Dickinson, Roche, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more